THERMotherapy Against Persistent Bacterial LUNG Infections
- Sponsor
- Chronic Obstructive Pulmonary Disease Trial Network, Denmark
- Study ID
- NCT05351242
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Asthma
- Bronchiectasis
- Chronic Lung Infections
- Chronic Obstructive Pulmonary Disease
- Copd
- Lung Diseases, Obstructive
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Thermotherapy/sauna bath — OTHERThermotherapy/sauna bath
Study Details
The aim of this study is to determine whether an intervention with frequent thermotherapy will be able to reduce the amount of colonizing bacteria in the bronchoalveolar lavage sample and eradicate the colonizing bacteria.
Key Dates
- First listed
- Apr 28, 2022
- Start date
- Oct 1, 2026
- Status verified
- Jun 2026
- Primary completion
- Dec 31, 2029
- Completion
- Dec 31, 2029
Study Design
- Enrollment
- 150 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Thermotherapy/sauna bathMust go to a sauna (min. Temperature 85℃) min. 4 times a week for 6 months. Each sauna bath must last at least 7 minutes. The intervention patients receive a subscription card for a sauna during the period. Patients will still receive pre-existing treatment
- No Intervention: No thermotherapy/sauna bathNot allowed to go to a sauna for 6 months. Patients who come to do so, by e.g. an oversight, however, remain in the study, to avoid introducing bias. It will be registered as a "protocol violation", but the patient will be included in Intention To Treat analysis and modified Intention To Treat analysis. Patients will still receive pre-existing treatment.
Primary Outcome Measure
Number of days from baseline without antibiotic treatment against pulmonary infection [ Time Frame: 6 months ]
Central Contacts
- Josefin V Eklöf, MD38673555
- Jens-Ulrik S Jensen, Professor38673057
Find similar trials
Related Studies
- Role of Genetic Factors in the Development of Lung DiseaseRecruiting · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland
- Emphysema Research Registry and Biosample RepositoryRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- Personalized Environment and Genes StudyRecruiting · National Institute of Environmental Health Sciences (NIEHS) · Chapel Hill, North Carolina
- Mechanism(s)of Airflow Limitation in Moderate-severe Persistent AsthmaRecruiting · Gelb, Arthur F., M.D. · Lakewood, California